Cookies on this site

A new research programme in emergency medicine begins today at the University of Oxford following a donation from the Kadoorie Foundation.

Horizontal portrait of David Metcalfe

Emergency medicine is the medical specialty that oversees the treatment of patients with injuries and emergencies.

There are over 28 million patient visits to NHS Emergency Departments (formerly ‘Accident & Emergency’) every year for everything from sprained ankles and broken wrists to heart attacks and major trauma. However, emergency medicine is a relatively young specialty and faces unique challenges as the number of patients and available treatments increase every year.

The new research programme will be led by David Metcalfe who becomes the inaugural Kadoorie Associate Professor of Emergency Medicine at the University of Oxford, a Consultant in Emergency Medicine at the John Radcliffe Hospital, and has been elected to a fellowship of Green Templeton College.

David will oversee the development of a research group within the university that will eventually include doctoral students, clinical academic trainees, and associated research staff. This team will deliver high-impact studies aimed at improving the safety and effectiveness of emergency care, both in the UK and globally.

David said: ‘We are going to focus on some of the biggest priorities in emergency care, such as improving the diagnosis of time-critical conditions, optimising clinical pathways so that the right patients get the right treatment at the right time, and rigorously testing treatments to improve patient outcomes and reduce downstream healthcare costs.’

The new programme will be based within the Kadoorie Centre for Critical Care Research and Education, which was made possible by The Honourable Sir Michael Kadoorie after he underwent emergency treatment at the John Radcliffe Hospital. The Kadoorie Centre has since transformed the research landscape across intensive care medicine and trauma surgery.

Professor Irene Tracey, Vice Chancellor of the University of Oxford, said: ‘In establishing a leading hub for emergency medicine research at Oxford, we hope to raise the profile of this important specialty and delivery research that will improve outcomes for the sickest and most severely injured patients. We are deeply grateful to the Kadoorie Foundation for continuing to help our researchers deliver the highest quality clinical studies.’

Professor Meghana Pandit, Chief Executive Officer at Oxford University Hospitals NHS Foundation Trust, said: ‘Ours is a research-active trust – and we value the way our strong clinical-academic partnership with the University of Oxford drives forward improvements in patient care, including in a vitally important area like emergency care. We welcome David’s appointment and what it means for the growing significance of emergency medicine. It comes at an exciting time for our Emergency Department which is now undergoing its biggest ever workforce expansion to meet the needs of patients across our region.’

Similar stories

New platform improves accuracy of molecular counting in RNA-sequencing

Researchers at NDORMS have developed a new computational platform to improve the accuracy of molecular counting in RNA-sequencing, helping scientists generate more reliable data for genetic research.

Professor Menna Clatworthy to join the Kennedy Institute at NDORMS

Professor Menna Clatworthy, recently announced as the new Regius Professor of Medicine at the University of Oxford, will join the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) as a Principal Investigator at the Kennedy Institute of Rheumatology with effect from March 2027. Professor Clatworthy will also join the Nuffield Department of Surgical Sciences highlighting the breadth and relevance of her research to multiple medical departments in Oxford.

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.